v3.25.1
Nature of Business and Significant Accounting Policies (Details Narrative)
3 Months Ended 6 Months Ended
Apr. 20, 2023
USD ($)
Mar. 31, 2025
USD ($)
shares
Mar. 31, 2024
USD ($)
shares
Mar. 31, 2025
USD ($)
Segment
shares
Mar. 31, 2024
USD ($)
shares
Schedule of Equity Method Investments [Line Items]          
Revenue | $  
Number of operating segment | Segment       1  
Convertible Notes Payable [Member]          
Schedule of Equity Method Investments [Line Items]          
Antidilutive securities   104,490,131 108,490,131 104,490,131 108,490,131
Share-Based Payment Arrangement, Option [Member]          
Schedule of Equity Method Investments [Line Items]          
Antidilutive securities   8,120,000   8,120,000  
Warrant [Member]          
Schedule of Equity Method Investments [Line Items]          
Antidilutive securities   15,387,050 15,387,050 15,387,050 15,387,050
Shares Issuable Upon Conversion of Series A Preferred and Series B Preferred Shares [Member]          
Schedule of Equity Method Investments [Line Items]          
Antidilutive securities   13,579,710 13,579,710 13,579,710 13,579,710
Discontinued Operations, Held-for-Sale [Member] | Purchase Agreement [Member]          
Schedule of Equity Method Investments [Line Items]          
Cash purchase price | $ $ 2,300,000